Cargando…
Time-dependent LPS exposure commands MSC immunoplasticity through TLR4 activation leading to opposite therapeutic outcome in EAE
BACKGROUND: Mesenchymal stem cells (MSCs) have been recognized for their regenerative and anti-inflammatory capacity which makes them very attractive to cell therapy, especially those ones to treat inflammatory and autoimmune disease. Two different immune-phenotypes have been described for MSCs depe...
Autores principales: | Kurte, Mónica, Vega-Letter, Ana María, Luz-Crawford, Patricia, Djouad, Farida, Noël, Danièle, Khoury, Maroun, Carrión, Flavio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520958/ https://www.ncbi.nlm.nih.gov/pubmed/32988406 http://dx.doi.org/10.1186/s13287-020-01840-2 |
Ejemplares similares
-
Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE
por: Vega-Letter, Ana María, et al.
Publicado: (2016) -
Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway
por: Luz-Crawford, Patricia, et al.
Publicado: (2012) -
IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis
por: Kurte, Mónica, et al.
Publicado: (2018) -
PPARβ/δ-dependent MSC metabolism determines their immunoregulatory properties
por: Contreras-Lopez, R. A., et al.
Publicado: (2020) -
Mesenchymal stem cells generate a CD4(+)CD25(+)Foxp3(+) regulatory T cell population during the differentiation process of Th1 and Th17 cells
por: Luz-Crawford, Patricia, et al.
Publicado: (2013)